Business Context and Reporting Period
Company: SANUWAVE Health, Inc. (SNWV)
Filing Type: Form 8-K (Current Report)
Report Date: August 6, 2026
Reporting Period: Second quarter ended June 30, 2026
The Company announced the release of its financial results for the second quarter of 2026 via a press release dated August 6, 2026. A business update conference call was scheduled for August 7, 2026.
Key Financial Metrics
The provided filing text serves as a notification of the results release and does not contain specific numerical data. The following metrics are not disclosed in this document:
- Revenue
- Profit/Loss
- Cash Flow
- Margins
- Debt and Liquidity
Note: Specific financial values are not present in the 8-K text provided; they are contained in the referenced press release (Exhibit 99.1) and conference call materials.
Material Changes
The filing does not provide comparative data or details regarding material changes versus the prior comparable period.
Guidance, Outlook, and Risks
Management Commentary: The Company indicated that a business update would be provided via a conference call on August 7, 2026, at 8:30 am EST.
Materials: Additional information is available on the Company's investor website (www.sanuwave.com/investors).
Risks and Contingencies: No specific risks, contingencies, or unusual items are detailed in this filing text.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for specific Q2 2026 revenue and earnings figures.
- Access the conference call materials or transcript scheduled for August 7, 2026, for management commentary and outlook.
- Verify the Company's liquidity position and debt levels in the full quarterly report (10-Q) if not detailed in the press release.
- Confirm any updates to the Company's strategic direction or product pipeline discussed during the business update.